General MedicationsORALGeneric
VERCYTE
PIPOBROMAN
Standard Dose
10MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: PRIORITY Marketing status: Discontinued
Summary
Approval overview VERCYTE is listed in Drugs@FDA under application 016245 (NDA).
Review priority: PRIORITY Marketing status: Discontinued Active ingredient PIPOBROMAN Form and strength TABLET;ORAL - 10MG Sponsor ABBOTT Submission history Latest submission status date: 1988-04-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview VERCYTE is listed in Drugs@FDA under application 016245 (NDA). Review priority: PRIORITY Marketing status: Discontinued Active ingredient PIPOBROMAN Form and strength TABLET;ORAL - 10MG Sponsor ABBOTT Submission history Latest submission status date: 1988-04-22 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: PRIORITY
Interaction Notes
- No interaction notes stored yet.